Pharmaceutical / Drug Definition :
Stimulates alpha- and beta-adrenergic receptors, causing relaxation of cardiac and bronchial smooth muscle and dilation of skeletal muscles. Also decreases aqueous humor production, increases aqueous outflow, and dilates pupils by contracting dilator muscle.
FDA Label Requirements and Exceptions
Epinephrine Bitartrate
FDA Import Information
Epinephrine Bitartrate
FDA Detentions
Epinephrine Bitartrate (Epinephrine Bitartrate Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Epinephrine Bitartrate (Epinephrine Bitartrate Suppliers)
- Processors Epinephrine Bitartrate
- Repackers Epinephrine Bitartrate
- Relabelers Epinephrine Bitartrate
- Exporters Epinephrine Bitartrate
- Importers Epinephrine Bitartrate
For more information about Epinephrine Bitartrate, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
